Being diagnosed with fibroids doesn’t automatically mean you need treatment. Many fibroids are discovered incidentally during routine pelvic exams or imaging for other reasons — and many never cause symptoms significant enough to warrant intervention.
But the flip side is equally important: too many women suffer with fibroid symptoms for years because they’re told to “wait and see” without clear guidance on what, exactly, they’re waiting for.
This article provides a framework for the watchful waiting vs. treatment decision — grounded in clinical guidelines, symptom assessment, and practical quality-of-life considerations.
When Watchful Waiting Is Appropriate
Asymptomatic fibroids. If your fibroids were discovered incidentally and you’re not experiencing heavy bleeding, pelvic pain, pressure, urinary symptoms, or back pain, observation is a perfectly reasonable approach. Many women live their entire lives with fibroids that never require treatment.
Small, stable fibroids. Fibroids that have been monitored on serial imaging and show minimal or no growth over 12–24 months are unlikely to suddenly cause problems. Continued monitoring at 6–12 month intervals is appropriate.
Perimenopausal women with manageable symptoms. Because fibroids are estrogen-responsive, most will shrink after menopause. If you’re within a few years of menopause and your symptoms are tolerable, waiting may be a reasonable strategy — provided your symptoms are truly tolerable and not just tolerated through resignation.
No anemia, no organ compression, no fertility impact. The absence of these red flags supports continued observation.
When It’s Time to Act
Certain clinical scenarios should prompt a shift from watching to treating.
Iron deficiency anemia. When heavy bleeding has depleted your iron stores to the point of anemia — confirmed by low hemoglobin or ferritin on blood work — you’ve crossed a threshold. Anemia means your body is being harmed by the bleeding, not just inconvenienced by it. Treatment should address the source.
Rapid fibroid growth. A fibroid that increases significantly in size over 6–12 months (typically defined as >20–30% volume increase) warrants evaluation. While rapid growth is usually benign, it can occasionally raise concern for leiomyosarcoma (a rare uterine malignancy), and it also suggests that symptoms are likely to worsen.
Urinary symptoms. Urinary frequency, urgency, nocturia, or difficulty emptying the bladder caused by fibroids compressing the bladder indicate organ-level impact that warrants treatment.
Pelvic pain or pressure affecting daily life. Chronic pelvic heaviness, lower back pain, or pain during intercourse that’s attributable to fibroids is a quality-of-life indicator that treatment can address.
Fertility impact. For women planning pregnancy, submucosal fibroids that distort the uterine cavity should generally be treated before conception.
Quality-of-life threshold. Perhaps the most important trigger is subjective: when your fibroids are limiting what you can do, where you can go, and how you live. If you’re planning your wardrobe around your period, canceling plans during your cycle, or feeling exhausted from chronic blood loss — that’s a quality-of-life burden that treatment can relieve.
The ‘Wait and See’ Trap
Here’s what we see too often in clinical practice: a woman with symptomatic fibroids is told to ‘watch and wait’ — but without a clear endpoint or criteria for when watching should become acting. Years pass. Symptoms worsen gradually. The anemia deepens. The quality of life erodes so slowly that each individual month seems manageable, even as the cumulative impact becomes substantial.
Watchful waiting is a valid clinical strategy when it’s structured — with defined monitoring intervals, clear symptom thresholds, and an honest discussion about when the balance tips from reasonable observation to unnecessary suffering.
If your doctor has recommended watchful waiting, ask: ‘What specific changes in symptoms, lab values, or imaging findings would prompt you to recommend treatment?’ If there’s no clear answer, the strategy may not be as thoughtful as it should be.
Frequently Asked Questions
Your Treatment Options When It’s Time to Act
When the decision shifts from watching to treating, the full spectrum of options should be discussed. UFE offers a same-day outpatient approach with 85–90% symptom improvement rates, one-to-two-week recovery, and uterine preservation. Myomectomy surgically removes fibroids while preserving the uterus. Hormonal therapy can manage symptoms as a bridge or temporizing measure. Hysterectomy is definitive but permanent.
At SACMD, our consultation process is designed to provide a complete, honest assessment of all options — with a recommendation tailored to your symptoms, fibroid characteristics, and life goals.
Schedule a consultation: Call (240) 427-1630 or visit www.sacmd.com
Disclaimer: This article is for informational purposes only and does not constitute medical advice.
References: -e 1. ACOG Practice Bulletin No. 228. Management of Symptomatic Uterine Leiomyomas. 2021. 2. Stewart EA. Uterine Fibroids. NEJM. 2015;372:1646-1655. 3. NIH/NICHD. Uterine Fibroids — Symptoms and Treatment Options. 4. Mayo Clinic. Uterine Fibroids — When to Consider Treatment. 5. Cleveland Clinic. Fibroids: Watchful Waiting vs Treatment.
